Cited research. Tiered protocols. Practical tools. The independent health publication for clinicians, informed self-experimenters, and anyone who wants the citations attached.
Every article runs the three filters: is the claim cited, is the protocol tiered, is every grey area named — not buried.
Wegovy, Zepbound, Mounjaro, and what's coming behind them. The trial data, the mechanism story, the cardiac and renal endpoints that nobody talked about until they were undeniable — and a tiered framework for thinking about all of it.
Read the long read →Framework first. Mechanism second. Evidence third. Protocol last. No supplement-bottle prose. No "studies show" without naming the study.
The GLP-1 class, the next-generation triple agonists, insulin resistance, CGMs, body composition. The class reshaping wellness.
Senolytics, mitochondrial protocols, fasting biology, rapamycin, NAD+, bioregulators. What moves healthspan vs. what's story.
Architecture, deep stages, REM. Why CBT-I beats most pills. Magnesium glycinate, apigenin, melatonin done right.
Nootropics with real mechanism. Focus, memory, neuroprotection. Why most "brain stacks" are marketing, and the few that aren't.
TRT, libido, fertility, thyroid, cortisol, HPA. The modern endocrine landscape — what's evidence, what's clinical art.
Tendon and joint repair, injury healing, sleep recovery, HRV. Tactical recovery for people training hard.
HPA dysregulation, depression biology, anxiolytic peptides, psychedelics, and the calm-state interventions that hold up.
Dermal collagen, hair, GHK-Cu, retinoids, peptide cosmetics. What's mechanism, what's marketing, what's both.
Microbiome, IBS, gastric peptides, Larazotide, BPC-157, motility. The gut–brain axis without the wellness mysticism.
Five rules that govern every long read, drug profile, hub page, and tool — and that make us a publication worth citing, worth subscribing to, and worth partnering with.
Inline references to primary studies. Effect size and sample size shown where it matters. No "studies show" without naming the study.
Conservative, standard, aggressive — with the trade-offs of each. You decide where you live on the spectrum, not us.
Regulatory status, off-label use, missing human trials, conflicting data. We don't smooth these over to make the page read cleaner.
Sponsorships and affiliate links are clearly labeled at the article level. Editorial judgment — what we cover and how — is independent of who's paying. The reader always knows what's commercial and what isn't.
Every article carries a "last reviewed against evidence" date and a change log. When new data reads out, the page moves with it.
| Standard health sites | Wellness Radar | |
|---|---|---|
| Sources cited | "Trusted source" links to WebMD / Mayo | Direct to PubMed, with effect size & n |
| Editorial review | "Medically reviewed" badge, no actual scrutiny | Named author, named methodology, COI disclosure |
| Recommendations | One hedged, generic answer | Conservative / Standard / Aggressive — with trade-offs |
| Update cadence | "Last updated" stamp; content unchanged for years | Reviewed against evidence each quarter; trial readouts integrated within weeks |
| Coverage scope | Skip peptides, longevity, biohacking entirely | Full coverage of what people actually use |
| Tools | BMI calculator. From 2010. | Reconstitution, dose planner, lab interpreter, stack tracker |
| Voice | Committee-flat. Sanded of opinion. | Authoritative. Direct. Anti-hype, not contrarian. |
The math you shouldn't have to do on a napkin. More tools added monthly — reconstitution, dose, cycle, half-life, protein.
Vial size, BAC water volume, target dose. Get unit marks on a U-100 syringe and a clear printable label. Handles every common peptide.
Open calculator →Map a full cycle — loading phase, maintenance, washouts. Cumulative exposure, projected cost, and re-dose timing across multiple peptides.
Open planner →Honest energy math. Mifflin-St Jeor + activity factor + goal-adjusted macros. No back-end pushing protein powder you don't need.
Open calculator →Paste your lab values, get plain-English context. Reference ranges, optimal vs. acceptable, and what each marker actually tells you.
Open interpreter →Steady-state time, washout windows, plasma concentration curves. The pharmacokinetics math the package insert doesn't show you.
Open calculator →Daily protein in grams, per-meal split, leucine-threshold math. Built for GLP-1 cuts, recomp, hypertrophy, and age-related anabolic resistance.
Open calculator →Drug profiles, peptide encyclopedia, supplement database, lab interpretation, glossary. Every claim in every article links back to the entry behind it.
90+ peptide profiles. Mechanism, dosing, evidence tier, sourcing notes. From GLP-1s to GHK-Cu to the Khavinson bioregulators.
A–Z pharmacology. Mechanism, dosing, brand names, contraindications, cost. Cited and updated each quarter against new trial readouts.
What works, what doesn't, and what's still ambiguous. Each entry tagged by mechanism, evidence tier, and where it sits in our framework.
Every marker — reference range, optimal range, what high vs. low actually means, and how clinicians read it in context. Plain English.
All 40 short peptides — Epitalon, Vesugen, Vilon, the rest. Mechanism, the Russian trial record, and how to read the evidence honestly.
Every acronym, every mechanism term, every trade name. So you never have to leave the article to know what something means.